Pain Patch Market Research Report - Forecast till 2027

Pain Patch Market Research Report: By Type (Opioid, Non-Opioid), By Mode of Administration (Microneedle Patches, Active Delivery Systems with Patches), By Therapeutic Use (Neurological Disorder, Cancer, Smoking Cessation, Others) and By End Users (Hospitals and Clinics, Home Care, Other) – Forecast to 2027

ID: MRFR/HC/7097-HCR | February, 2021 | Region : Global

Pain Patch Market Forecast


Pain Patch Market is expected to cross USD 29.5 Billion by 2025 at a CAGR of 4.8%.


Market Synopsis


Pain patches are the transdermal therapeutic system (TTS), which contain active substances that are absorbed by the skin and distributed into the body through the bloodstream.


The companies involved in developing pain patches develop pain patches for different therapeutic applications such as neurological pain, arthritis, osteoporosis, and others. For instance, in June 2019, NanoVibronix a medical device company announced they are planning to launch of CBD infused patch in combination with cream for the PainShield system a therapeutic ultrasound product used for pain management. Additionally, in August 2015 Mylan N.V. launched Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm for post-herpetic neuralgia (PHN). The launch of new products and technology by companies is also projected to boost the pain patch market growth.


Market Influencer


Increasing demand for easy to use pain management product drives the pain patch market.


Market Drivers



  • Increasing demand for easy to use, painless, and convenient mode of pain management drives pain patch market growth.



  • The geriatric population, young people, and huge patient groups having problems in swallowing or who are suffering from vomiting or emesis increase the demand for transdermal patches.



  • The increasing prevalence of neurological disorders such as Alzheimer's, Parkinson’s disease (PD), and others. Exelon patch distributed by Novartis Pharmaceuticals Corporation is a prescription medicine used to treat the above-mentioned neurological disorder. The growing patient population with a memory problem or other brain-related problems boosts the demand for pain patches.



  • In addition, increasing adoption of opioids for pain management related to trauma and injury in severe and in cases of post-surgical pain is driving pain patch market growth.


Market Restraints



  • Extended use of patches causing side effects such as vomiting, weakness, allergic reaction hampers the pain patch market growth.



  • Availability of alternative pain management products


Pain Patch Market Segmentation


By Type



  • Opioid: The opioid segment for pain management is further sub-segmented into, immediate-release and extended-release. The immediate-release patches release the opioid quickly as it comes in contact with skin, but their effect lasts for a shorter period. Whereas extended-release patches release the drug for a longer period. By type, opioid is the largest segment owing to its availability in the pain patch market and increasing demand for pain management.



  • Non-Opioid: It is the fastest-growing segment by type. There is an increase in demand for non-opioid pain patches, as it is considered as less addictive and safe. NanoVibronix, a healthcare company, is planning to launch a combination of PainShield and nanoparticle CBD-infused patch/cream as an alternative to opioids for pain treatment.


By Mode of Administration



  • Microneedle Patches: Holds the largest segment by mode of administering. There are different types of microneedle patches, such as hollow microneedles, solid microneedles, dissolving microneedles, and others. The availability of different patches increases the demand for this type of pain management products.



  • Active Delivery Systems with Patches: pain patch market is the fastest-growing segment. These are active patches works with active systems example, iontophoresis. These patches conduct small current through which active substances are transferred into the body. LTS Lohmann Therapie-Systeme AG offers such type of active patches for pain management.


By Therapeutic Use



  • Neurological Disorder: It is the largest segment by therapeutic application. In a neurological disorder, the pain patches are used for Alzheimer's disease, Parkinson's disease, and neuropathic pain.



  • Cancer: High doses of opioid patches are used to control their cancer pain.



  • Smoking Cessation: The nicotine administration patches reduce the pain in both smokers and nonsmokers.



  • Others: The other segment include skincare, spinal pain, neck pain, and others.


By End Users



  • Hospitals and Clinics: Hospitals are the primary points for diagnosis and treatment for individuals. The increase in patient visits to hospitals for the diagnosis increases the segmental growth.



  • Home Care: Holds the largest market share. The pain patches can be used by the patient itself at home due to the ease of use and convenience.



  • Other: This segment includes surgical centers, rehabilitation centers, and others.


By Region



  • Americas: The Americas is the largest regional market. An increasing number of chronic diseases, neurological disease, spinal injury, and other health problems is likely to drive the growth of the market during the assessment period. In the Americas, 5 million people are living with Alzheimer’s disease, and the number is expected to grow if not treated. Such a large population suffering from neurological disorder increases the demand for pain patches market in this region.



  • Europe: Europe has a large number of healthcare companies providing diagnostic and treatment products for pain management to drive pain patch market growth in this region.



  • Asia-Pacific: The fastest-growing regional market for pain patch, Asia-Pacific, has a huge population suffering from back pain, neck pain, and sedentary lifestyle. Also, increasing accidental cases in this region are likely to drive the growth of the pain patch market.



  • Middle East & Africa: The developing healthcare infrastructure and growing treatment options for pain management boost the pain patch market growth in this region.


Pain Patch Market Key Players



  • LTS Lohmann Therapie-Systeme AG (Germany)

  • (US)

  • Mylan N.V.(US)

  • Pfizer, Inc. (US)

  • Teva Pharmaceutical Company (Allergan Plc (Actavis)) (Israel)

  • Endo Pharmaceuticals Inc (Israel)

  • Hisamitsu America, Inc. (America)

  • Johnson & Johnson (US)

  • Teikoku Seiyaku Co., Ltd (Japan)

  • Sanofi (France)

  • NICHIBAN Co (Japan)

  • The Mentholatum Company (US)

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Pain Patch Market, by Type

1.1.2. Global Pain Patch Market, by Mode of Administration

1.1.3. Global Pain Patch Market, by Therapeutic Use

1.1.4. Global Pain Patch Market, by End Users

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL PAIN PATCH MARKET, BY TYPE

6.1. Overview

6.2. Opioid

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Immediate-Release

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Extended-Release

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Non-Opioid

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL PAIN PATCH MARKET, BY MODE OF ADMINISTRATION

7.1. Overview

7.2. Microneedle Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Active Delivery Systems with Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL PAIN PATCH MARKET, BY THERAPEUTIC USE

8.1. Overview

8.2. Neurological Disorder

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Smoking Cessation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL PAIN PATCH MARKET, BY END USERS

9.1. Overview

9.2. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3. Home Care

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10. GLOBAL PAIN PATCH MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitor Dashboard

11.3. Major Growth Strategy in the Global Pain Patch Market

11.4. Competitive Benchmarking

11.4.1. The Leading Player in terms of Number of Developments in the Global Pain Patch Market

11.5. Key Developments & Growth Strategies

11.6. Major Players Financial Matrix & Market Ratio

12. COMPANY PROFILES

12.1. LTS Lohmann Therapie-Systeme AG

12.1.1. Company Overview

12.1.2. Products/Services Offered

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. NanoVibronix.

12.3. Mylan N.V.

12.4. Pfizer, Inc.

12.5. Teva Pharmaceutical Company (Allergan Plc (Actavis))

12.6. Endo Pharmaceuticals Inc

12.7. Hisamitsu America, Inc.

12.8. Johnson & Johnson

12.9. Teikoku Seiyaku Co., Ltd.

12.10. Sanofi

12.11. NICHIBAN Co

12.12. The Mentholatum Company

12.13. Others

13. APPENDIX

13.1. References

13.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL PAIN PATCH MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL PAIN PATCH MARKET ESTIMATES & FORECAST, 2020-2027(USD MILLION)

TABLE 3 GLOBAL PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 4 GLOBAL PAIN PATCH MARKET, BY MODE OF ADMINISTRATION, 2020-2027(USD MILLION)

TABLE 5 GLOBAL PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 6 GLOBAL PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 7 GLOBAL PAIN PATCH MARKET, BY REGION, 2020-2027(USD MILLION)

TABLE 8 NORTH AMERICA: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 9 NORTH AMERICA: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION, 2020-2027(USD MILLION)

TABLE 10 NORTH AMERICA: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 11 NORTH AMERICA: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 12 US: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 13 US: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION, 2020-2027(USD MILLION)

TABLE 14 US: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 15 US: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 16 CANADA: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 17 CANADA: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION 2020-2027(USD MILLION)

TABLE 18 CANADA: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 19 CANADA: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 20 LATIN AMERICA: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 21 LATIN AMERICA: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION, 2020-2027(USD MILLION)

TABLE 22 LATIN AMERICA: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 23 LATIN AMERICA: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 24 EUROPE: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 25 EUROPE: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION, 2020-2027(USD MILLION)

TABLE 26 EUROPE: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 27 EUROPE: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 28 WESTERN EUROPE: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 29 WESTERN EUROPE: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION 2020-2027(USD MILLION)

TABLE 30 WESTERN EUROPE: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 31 WESTERN EUROPE: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 32 EASTERN EUROPE: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 33 EASTERN EUROPE: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION 2020-2027(USD MILLION)

TABLE 34 ESATERN EUROPE: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 35 EASTERN EUROPE: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 36 ASIA-PACIFIC: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 37 ASIA-PACIFIC: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION, 2020-2027(USD MILLION)

TABLE 38 ASIA-PACIFIC: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 39 ASIA-PACIFIC: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: PAIN PATCH MARKET, BY TYPE, 2020-2027(USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: PAIN PATCH MARKET, BY MODE OF ADMINISTRATION, 2020-2027(USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: PAIN PATCH MARKET, BY THERAPEUTIC USE, 2020-2027(USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: PAIN PATCH MARKET, BY END USERS, 2020-2027(USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PAIN PATCH MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PAIN PATCH MARKET

FIGURE 4 GLOBAL PAIN PATCH MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL PAIN PATCH MARKET SHARE, BY MODE OF ADMINISTRATION 2020 (%)

FIGURE 6 GLOBAL PAIN PATCH MARKET SHARE, BY THERAPEUTIC USE 2020 (%)

FIGURE 7 GLOBAL PAIN PATCH MARKET SHARE, BY END USERS, 2020 (%)

FIGURE 8 GLOBAL PAIN PATCH MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 AMERICAS: PAIN PATCH MARKET SHARE BY REGION, 2020 (%)

FIGURE 10 NORTH AMERICA: PAIN PATCH MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 EUROPE: PAIN PATCH MARKET SHARE, BY REGION, 2020 (%)

FIGURE 12 WESTERN EUROPE: PAIN PATCH MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 ASIA-PACIFIC: PAIN PATCH MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 MIDDLE EAST & AFRICA: PAIN PATCH MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 15 GLOBAL PAIN PATCH MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 16 LTS LOHMANN THERAPIE-SYSTEME AG: KEY FINANCIALS

FIGURE 17 LTS LOHMANN THERAPIE-SYSTEME AG: SEGMENTAL REVENUE

FIGURE 18 LTS LOHMANN THERAPIE-SYSTEME AG: REGIONAL REVENUE

FIGURE 19 NANOVIBRONIX.: KEY FINANCIALS

FIGURE 20 NANOVIBRONIX.: SEGMENTAL REVENUE

FIGURE 21 NANOVIBRONIX.: REGIONAL REVENUE

FIGURE 22 MYLAN N.V.: KEY FINANCIALS

FIGURE 23 MYLAN N.V.: SEGMENTAL REVENUE

FIGURE 24 MYLAN N.V.: REGIONAL REVENUE

FIGURE 25 PFIZER, INC.: KEY FINANCIALS

FIGURE 26 PFIZER, INC.: SEGMENTAL REVENUE

FIGURE 27 PFIZER, INC.: REGIONAL REVENUE

FIGURE 28 TEVA PHARMACEUTICAL COMPANY (ALLERGAN PLC (ACTAVIS)): KEY FINANCIALS

FIGURE 29 TEVA PHARMACEUTICAL COMPANY (ALLERGAN PLC (ACTAVIS)): SEGMENTAL REVENUE

FIGURE 30 TEVA PHARMACEUTICAL COMPANY (ALLERGAN PLC (ACTAVIS)): REGIONAL REVENUE

FIGURE 31 ENDO PHARMACEUTICALS INC: KEY FINANCIALS

FIGURE 32 ENDO PHARMACEUTICALS INC: SEGMENTAL REVENUE

FIGURE 33 ENDO PHARMACEUTICALS INC: REGIONAL REVENUE

FIGURE 34 HISAMITSU AMERICA, INC.: KEY FINANCIALS

FIGURE 35 HISAMITSU AMERICA, INC.: SEGMENTAL REVENUE

FIGURE 36 HISAMITSU AMERICA, INC.: REGIONAL REVENUE

FIGURE 37 JOHNSON & JOHNSON: KEY FINANCIALS

FIGURE 38 JOHNSON & JOHNSON: SEGMENTAL REVENUE

FIGURE 39 JOHNSON & JOHNSON: REGIONAL REVENUE

FIGURE 40 TEIKOKU SEIYAKU CO., LTD.: KEY FINANCIALS

FIGURE 41 TEIKOKU SEIYAKU CO., LTD.: SEGMENTAL REVENUE

FIGURE 42 TEIKOKU SEIYAKU CO., LTD.: REGIONAL REVENUE

FIGURE 43 SANOFI: KEY FINANCIALS

FIGURE 44 SANOFI: SEGMENTAL REVENUE

FIGURE 45 SANOFI: REGIONAL REVENUE

FIGURE 46 NICHIBAN CO: KEY FINANCIALS

FIGURE 47 NICHIBAN CO: SEGMENTAL REVENUE

FIGURE 48 NICHIBAN CO: REGIONAL REVENUE

FIGURE 49 THE MENTHOLATUM COMPANY: KEY FINANCIALS

FIGURE 50 THE MENTHOLATUM COMPANY: SEGMENTAL REVENUE

FIGURE 51 THE MENTHOLATUM COMPANY: REGIONAL REVENUE




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Pain Patch Market